<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Germany</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Germany.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/de.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Point prevalence assessments of five respiratory viruses in adults ≥ 50 years of age in Germany by multi-pathogen rapid antigen testing on June 1, 2024, and December 15, 2024.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors propose that community-based screening can help identify asymptomatic viral reservoirs and underreported viral circulation, such as adenovirus, linking viral detection to clinical and economic impact.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effectiveness of seasonal mRNA COVID-19 vaccination against post COVID-19 condition between July 2023 and September 2024 among adults aged ≥ 60 years in Germany: a population-based cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13803-8-cf9a44fe/</guid>
    <pubDate>Sat, 13 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings address vaccine-preventable PCC burden in a high-risk age group during the first post-pandemic season and are positioned as input for vaccination policy, communication, and clinical decision-making.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Health policy</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Outpatient care intensity and influenza vaccination: evidence from Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128038-08023539/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2025-128038-08023539/</guid>
    <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
    <description>The authors present the findings as showing that influenza vaccination coverage remains below target in the groups examined. The study suggests that routine review of vaccination status during outpatient encounters may be an important opportunity for improving uptake in adults with chronic conditions and older adults.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Low frequency of N-methyl-D-aspartate receptor autoimmunity in tick-borne encephalitis.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0334438-1e257657/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0334438-1e257657/</guid>
    <pubDate>Mon, 13 Oct 2025 00:00:00 GMT</pubDate>
    <description>The authors note that diagnostic evaluation might be warranted for individuals experiencing delayed neurological decline, though the low prevalence limits broad applicability.</description>
    <category>Tick-borne encephalitis</category>
    <category>Japanese Encephalitis</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-25-00018-0-0c50fdeb/</guid>
    <pubDate>Tue, 01 Jul 2025 00:00:00 GMT</pubDate>
    <description>The article provides Germany-specific observational evidence on MVA-BN safety and estimated effectiveness in the population studied during the 2022-2023 mpox period. Its findings may inform editorial context about vaccination evidence, including the reported difference in estimated effectiveness by HIV status, but they do not establish causality or confirm a current surveillance pattern.</description>
    <category>Smallpox</category>
    <category>Monkeypox</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Using the WHO-INTEGRATE framework to develop a COVID-19 guideline for schools, Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-blt-24-291550-07993e23/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-blt-24-291550-07993e23/</guid>
    <pubDate>Tue, 01 Oct 2024 00:00:00 GMT</pubDate>
    <description>The guideline addressed a critical gap in reliable, globally applicable recommendations for safe and continuous school operations during the COVID-19 pandemic. The WHO-INTEGRATE framework supported transparent, structured decision-making with a whole-of-society perspective on measures to reduce SARS-CoV-2 transmission in schools.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Health policy</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Guideline</category>
  </item>
  <item>
    <title>Emergence of swine influenza A virus, porcine respirovirus 1 and swine orthopneumovirus in porcine respiratory disease in Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2023-2239938-c9291120/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2023-2239938-c9291120/</guid>
    <pubDate>Wed, 02 Aug 2023 00:00:00 GMT</pubDate>
    <description>The findings highlight the ongoing zoonotic potential of swine influenza A viruses, as demonstrated by the 2009 human pandemic, and emphasize the importance of pathogen monitoring in pig populations. The emergence of PRV1 and SOV as potential contributors to porcine respiratory disease syndrome may complicate disease control efforts.</description>
    <category>Influenza</category>
    <category>Gastroenteritis</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</guid>
    <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
    <description>The registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in children</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-022-30664-2-dd9d5bba/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-022-30664-2-dd9d5bba/</guid>
    <pubDate>Sat, 25 Jun 2022 00:00:00 GMT</pubDate>
    <description>The method addresses practical barriers to pediatric SARS-CoV-2 surveillance by combining non-invasive sample collection with high-throughput capacity. The approach demonstrated feasibility for large-scale infection control in educational settings.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Diagnostics</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Results of the enhanced COVID-19 surveillance during UEFA EURO 2020 in Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1017-s0950268822000449-3baf8d0e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1017-s0950268822000449-3baf8d0e/</guid>
    <pubDate>Thu, 03 Mar 2022 00:00:00 GMT</pubDate>
    <description>The findings suggest that mass gathering events can be conducted with limited COVID-19 transmission when health measures for attendees and restrictions on large public viewing are in place. The results underscore the importance of surveillance and public health regulations during mass gatherings.</description>
    <category>COVID-19</category>
    <category>Travel medicine</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mental health concerns during the COVID-19 pandemic as revealed by helpline calls</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41586-021-04099-6-423ff1a2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41586-021-04099-6-423ff1a2/</guid>
    <pubDate>Wed, 17 Nov 2021 00:00:00 GMT</pubDate>
    <description>The study demonstrates that helpline data can provide real-time monitoring of mental health concerns during public health crises, complementing established surveillance approaches. The findings suggest that financial relief measures may mitigate psychological distress associated with lockdown policies.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Health policy</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41586-020-2814-7-75716238/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41586-020-2814-7-75716238/</guid>
    <pubDate>Wed, 30 Sep 2020 00:00:00 GMT</pubDate>
    <description>Early immunogenicity metrics indicate that the formulation triggers complementary defense pathways, positioning it as a candidate tool for future pandemic mitigation strategies pending larger efficacy evaluations.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16–17, Berlin, Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2019-07-079-5acc579b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2019-07-079-5acc579b/</guid>
    <pubDate>Tue, 01 Oct 2019 00:00:00 GMT</pubDate>
    <description>Health worker vaccination addresses dual risks of occupational infection and transmission to vulnerable patients, while also supporting pandemic preparedness. The guidance aims to help countries without policies establish them and to improve low coverage where policies exist.</description>
    <category>Influenza</category>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Modelling norovirus transmission and vaccination</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-07-053-3cb3ac60/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2018-07-053-3cb3ac60/</guid>
    <pubDate>Sat, 01 Sep 2018 00:00:00 GMT</pubDate>
    <description>Norovirus causes approximately one-fifth of acute gastroenteritis cases globally each year. With vaccines in clinical trials, model-based predictions can inform immunisation policy design and help optimize allocation across age groups depending on whether infection prevention or severe outcome prevention is prioritized.</description>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Vaccine effectiveness</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Dot map cartograms for detection of infectious disease outbreaks: an application to Q fever, the Netherlands and pertussis, Germany</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-26-30562-23bed950/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-26-30562-23bed950/</guid>
    <pubDate>Thu, 29 Jun 2017 00:00:00 GMT</pubDate>
    <description>Dot map cartograms may support outbreak detection and visualization by public health professionals, facilitating informed decisions for investigation and control activities.</description>
    <category>Pertussis</category>
    <category>Q fever</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>One Health</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2015-20-42-30046-aa85d151/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2015-20-42-30046-aa85d151/</guid>
    <pubDate>Thu, 22 Oct 2015 00:00:00 GMT</pubDate>
    <description>The report highlights the need for clinicians caring for refugees traversing north Africa to recognise louse-borne relapsing fever, in order to provide timely treatment and apply preventive measures.</description>
    <category>Relapsing fever</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Autochthonous dengue fever in Croatia, August–September 2010</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-ese-16-09-19805-en-18529895/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-ese-16-09-19805-en-18529895/</guid>
    <pubDate>Thu, 03 Mar 2011 00:00:00 GMT</pubDate>
    <description>The report documents the first apparent autochthonous dengue transmission in Croatia, demonstrating the value of cross-border case notification and the role of heightened clinical awareness combined with vector control in detecting and containing local arboviral transmission.</description>
    <category>Dengue</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Food-borne norovirus-outbreak at a military base, Germany, 2009</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-1471-2334-10-30-d48764a2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-1471-2334-10-30-d48764a2/</guid>
    <pubDate>Wed, 17 Feb 2010 00:00:00 GMT</pubDate>
    <description>The investigation demonstrated food-borne norovirus transmission through contaminated salad at a communal dining facility. Control measures included cohort isolation, exclusion of norovirus-positive food handlers, and kitchen disinfection, emphasizing the importance of strict hygiene and proper environmental disinfection.</description>
    <category>Gastroenteritis</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Transmission dynamics</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>furter efforts needed to achieve measles elimination in Germany: results of an outbreak investigation</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2471-blt-07-050187-7ce8d4db/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2471-blt-07-050187-7ce8d4db/</guid>
    <pubDate>Sun, 01 Feb 2009 00:00:00 GMT</pubDate>
    <description>The findings demonstrate ongoing challenges to measles elimination in Germany, highlighting significant immunity gaps in older pediatric age groups that may undermine control strategies.</description>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Outbreak investigation</category>
  </item>
  <item>
    <title>Interferon- Release Assays Improve the Diagnosis of Tuberculosis and Nontuberculous Mycobacterial Disease in Children in a Country with a Low Incidence of Tuberculosis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1086-519266-4d93f48c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1086-519266-4d93f48c/</guid>
    <pubDate>Wed, 01 Aug 2007 00:00:00 GMT</pubDate>
    <description>The findings suggest IGRAs can reduce overdiagnosis and unnecessary treatment of tuberculosis in children by improving specificity, particularly in settings with nontuberculous mycobacterial disease and bacille Calmette-Guerin vaccination.</description>
    <category>Tuberculosis</category>
    <category>Diagnostics</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
